DANISHEFSKY SAMUEL J.,YANG GUANGBIN,IYER KARTHIK,RAGUPATHI GOVIND,LIVINGSTON PHILIP O.,ZHU JIANGLONG
申请号：
NZ60408911
公开号：
NZ604089A
申请日:
2011.06.10
申请国别(地区):
NZ
年份:
2015
代理人:
摘要：
Disclosed is the use of a therapeutically effective amount of an immunogenic glycoconjugate in the manufacture of a medicament for treating ovarian cancer in a subject suffering therefrom, wherein the immunogenic glycoconjugate comprises a multi-antigenic glycopeptide having a peptidic backbone made up of at least five amino acid residues, wherein five or more of said amino acids independently have a structure as defined in the complete specification.
